New Mexico Educational Retirement Board decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

Biogen (BIIB) and Stoke Therapeutics (STOK) announced a collaboration for the development and commercialization of zorevunersen, a potential ...

Piper Sandler analyst David Amsellem lowered the firm’s price target on Biogen (BIIB) to $135 from $138 and keeps a Neutral rating on the ...

Under the terms of the deal, Bedford, Mass.-based Stoke (STOK) will retain exclusive rights for the treatment called zorevunersen in the U.S., Canada and Mexico, while Cambridge, Mass.-based Biogen ...

Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics in ophthalmology, today announced the closing of a $15M Series A funding round including Deerfield Management, ...

Office is now Microsoft 365, the premier productivity suite with innovative productivity apps, intelligent cloud services, and world-class security. Office.com, the Office mobile app, and the Office ...